## 12-Bromododecanoic Acid: A Versatile Building Block for Research
12-Bromododecanoic acid is a **fatty acid** with a bromine atom attached to the 12th carbon atom. This seemingly simple molecule plays a crucial role in various research fields due to its **versatile chemical properties** and its ability to serve as a **building block** for more complex structures.
Here's a breakdown of its importance:
**1. Synthesis of Bioactive Molecules:**
- **Polyesters and Polymers:** The bromine atom allows for facile **alkylation reactions** with other molecules. This makes 12-bromododecanoic acid an ideal starting material for synthesizing various polyesters and polymers with tailored properties. These polymers find applications in areas like **drug delivery**, **biomaterials**, and **coatings**.
- **Surfactants:** Its long carbon chain and reactive bromine group can be utilized to synthesize **amphiphilic molecules**, which act as surfactants. These surfactants are essential for a variety of applications, including **detergents**, **emulsifiers**, and **biocompatible coatings**.
**2. Development of Novel Materials:**
- **Self-Assembling Systems:** The bromine group can be used to introduce functionalities for **self-assembly**. This allows for the creation of complex, ordered structures that have applications in areas like **nanotechnology**, **biomimicry**, and **functional materials**.
- **Biocompatible Materials:** Its hydrophobic tail and hydrophilic head provide an excellent platform for developing **biocompatible materials** with diverse functionalities. This opens up potential applications in **tissue engineering**, **drug delivery**, and **biomedical devices**.
**3. Studying Biological Processes:**
- **Lipid Metabolism:** 12-bromododecanoic acid can be used as a **probe** to study **lipid metabolism** in living organisms. Its radiolabeled form can be used to track its uptake, distribution, and metabolism within cells, providing insights into lipid transport and storage.
- **Cell Signaling:** The molecule can be incorporated into **synthetic lipids**, which can then be used to study **cell signaling pathways** involved in various physiological processes like inflammation, immune responses, and cell growth.
**4. Industrial Applications:**
- **Lubricants:** 12-bromododecanoic acid can be used as a precursor for producing **lubricants**, which are essential in a variety of industries, including automotive, aerospace, and manufacturing.
- **Flame Retardants:** The bromine atom can be incorporated into polymers to produce **flame retardant materials**, enhancing safety in various applications like construction materials and textiles.
**In conclusion**, 12-bromododecanoic acid is a versatile molecule with significant potential in diverse research fields. Its ability to act as a building block for synthesizing novel bioactive molecules, materials, and probes makes it an invaluable tool for researchers exploring new frontiers in chemistry, biology, and materials science.
12-bromododecanoic acid : A bromo fatty acid consisting of lauric acid having a single bromo-substituent at the 12-position.
ID Source | ID |
---|---|
PubMed CID | 175468 |
CHEMBL ID | 1231458 |
CHEBI ID | 49519 |
SCHEMBL ID | 93186 |
MeSH ID | M0107227 |
Synonym |
---|
CHEMBL1231458 |
nsc-660375 |
BRC , |
12-bromododecanoic acid |
nsc660375 |
LMFA01090007 |
12-bromo-dodecanoic acid |
DB02405 |
12-bromododecanoic acid, 97% |
73367-80-3 |
12-brom-dodecansaeure |
12-br 12:0 |
CHEBI:49519 , |
12-bromolauric acid |
c12-br 12:0 |
12-bromo-1-dodecanoic acid |
A837812 |
unii-rp072zq00e |
einecs 277-401-4 |
dodecanoic acid, 12-bromo- |
rp072zq00e , |
cas-73367-80-3 |
NCGC00260413-01 |
tox21_202867 |
dtxsid1049354 , |
dtxcid8029313 |
AKOS015893930 |
SCHEMBL93186 |
mfcd00002738 |
SY037168 |
FT-0711808 |
AS-47313 |
Q27093407 |
AMY25771 |
F13219 |
EN300-87132 |
PD008361 |
CS-0158383 |
Class | Description |
---|---|
bromo fatty acid | Any halo fatty acid containing at least one bromo substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 56.5653 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 5.9391 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521; AID1159523 |
SMAD family member 2 | Homo sapiens (human) | Potency | 27.6132 | 0.1737 | 34.3047 | 61.8120 | AID1346859 |
SMAD family member 3 | Homo sapiens (human) | Potency | 27.6132 | 0.1737 | 34.3047 | 61.8120 | AID1346859 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 68.7291 | 0.0007 | 14.5928 | 83.7951 | AID1259369 |
AR protein | Homo sapiens (human) | Potency | 26.4583 | 0.0002 | 21.2231 | 8,912.5098 | AID743036; AID743053 |
caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 24.3860 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 53.5658 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224893 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 28.4745 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159553; AID1159555 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 61.1459 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1224848; AID1224849; AID1259401; AID1259403 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 49.1040 | 0.3758 | 27.4851 | 61.6524 | AID743220 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 51.7422 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075; AID743079 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 54.4042 | 0.0010 | 19.4141 | 70.9645 | AID743094; AID743140; AID743191 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 50.4115 | 0.0237 | 23.2282 | 63.5986 | AID743222; AID743223 |
caspase-3 | Homo sapiens (human) | Potency | 24.3860 | 0.0133 | 26.9810 | 70.7614 | AID1346978 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 54.5935 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 25.8738 | 0.0376 | 17.0823 | 61.1927 | AID1259364; AID1259388 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 58.6928 | 0.0006 | 27.2152 | 1,122.0200 | AID743202; AID743219 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 38.6492 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.43) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |